By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teva Parenteral Medicines, Inc. 

19 Hughes

Irvine  California  92618  U.S.A.
Phone: 949-455-4700 Fax: 949-855-8210


Teva Parenteral Medicines, Inc., a wholly owned subsidiary of Teva Pharmaceuticals USA, is a leader in the development and marketing of generic injectables. Using internal Research and Development capabilities, together with operational flexibility and manufacturing and regulatory expertise, Teva is able to take a wide variety of products from the laboratory to the market.

Teva Pharmaceuticals USA is a leading generic pharmaceutical company, marketing products from a wide range of therapeutic areas including analgesic, anti-infective, cardiovascular, oncology, CNS, dermatological and anti-inflammatory. Dosage forms include extended and immediate release tablets and capsules, injectables, creams, ointments, solutions and suspensions. Teva USA has an aggressive Research and Development effort and one of the best overall ANDA approval records in the industry.

Our mission is to play a leading role in the transformation of the U.S. healthcare system through its preeminence in the development, manufacture and marketing of generic pharmaceuticals.

Key Statistics

Ownership: Subsidiary

Web Site: Teva Parenteral Medicines
Symbol: TEVA


Company News
Teva Parenteral Medicines (TEVA) Initiates Voluntary Nationwide Recall Of Select Lots Of Adrucil (Fluorouracil Injection, USP) 5 G/100 Ml (50 Mg/Ml) Due To Particulate Matter 7/24/2015 10:40:33 AM
The Medicines Company (MDCO) Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva Parenteral Medicines, Inc. (TEVA) 10/3/2011 8:53:53 AM
Cubist Pharmaceuticals, Inc. (CBST) Receives Claim Construction Order in Patent Infringement Action Against Teva Parenteral Medicines, Inc. (TEVA) 6/8/2010 10:25:21 AM
Cubist Pharmaceuticals, Inc. (CBST) Release: Markman Hearing Cancelled in Cubist Pharmaceuticals' Patent Infringement Action Against Teva Parenteral Medicines, Inc. (TEVA) 6/4/2010 9:22:35 AM
Trial Date Set for CUBICIN(R) Patent Litigation; Cubist Pharmaceuticals, Inc. (CBST) Litigation Against Teva Parenteral Medicines, Inc. (TEVA) 12/11/2009 10:32:51 AM
The Medicines Company (MDCO) Files Patent Infringement Lawsuits Against Teva Parenteral Medicines, Inc. (TEVA) And APP Pharmaceuticals 10/9/2009 8:27:29 AM
The Medicines Company (MDCO) Receives Paragraph IV Notifications 9/4/2009 9:25:28 AM
FDA Reports Current Drgu Shortage for Teva Parenteral Medicines, Inc. (TEVA)'s Zanosar (Streptozocin) Injection 8/26/2008 2:31:43 PM
Teva Pharmaceutical Industries Limited (TEVA) Announces Approval Of Fludarabine Phosphate Injection10/19/2005 5:11:06 PM
Teva Pharmaceutical Industries Limited (TEVA) Announces Settlement Of Carboplatin Litigation With Bristol-Myers Squibb Company (BMY)10/19/2005 5:11:04 PM